Telechelic poly(imide) oligomers, methods of manufacture, and uses thereof

US10696792B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10696792-B2
Application numberUS-201716347105-A
CountryUS
Kind codeB2
Filing dateNov 16, 2017
Priority dateNov 16, 2016
Publication dateJun 30, 2020
Grant dateJun 30, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A ureido-pyrimidinone oligomer having the formula (I) wherein each Z′ is independently the same or different, and is a substituted or unsubstituted straight or branched chain C 1-10 alkyl, each R 1 is independently the same or different, and is a substituted or unsubstituted straight or branched chain C 1-20 alkylene, substituted or unsubstituted C 2-20 alkenylene, substituted or unsubstituted C 3-8 cycloalkylene, or substituted or unsubstituted C 6-18 arylene, each V is independently the same or different, and is a substituted or unsubstituted tetravalent C 4-40 hydrocarbon group, each R is independently the same or different, and is a substituted or unsubstituted C 1-24 divalent hydrocarbon group; and n has an average value of 2 to 50, preferably 3 to 40, more preferably 5 to 30.

First claim

Opening claim text (preview).

What is claimed is: 1. A ureido-pyrimidinone oligomer having the formula wherein each Z′ is independently the same or different, and is a substituted or unsubstituted straight or branched chain C 1-10 alkyl, each R 1 is independently the same or different, and is a substituted or unsubstituted straight or branched chain C 1-20 alkylene, substituted or unsubstituted C 2-20 alkenylene, substituted or unsubstituted C 3-8 cycloalkylene, or substituted or unsubstituted C 6-18 arylene, each V is independently the same or different, and is a substituted or unsubstituted tetravalent C 4-40 hydrocarbon group, each R is independently the same or different, and is a substituted or unsubstituted C 1-24 divalent hydrocarbon group, and n has an average value of 2 to 50. 2. The oligomer of claim 1 , wherein Z′ is an unsubstituted C 1-3 alkyl, and R 1 is a straight chain C 3-10 alkylene. 3. The oligomer of claim 2 , wherein Z′ is methyl and R 1 is n-hexylene. 4. The oligomer of claim 1 , wherein V is a substituted or unsubstituted C 6-20 aromatic hydrocarbon group. 5. The oligomer of claim 1 , wherein V is wherein W is —O—, —S—, —C(O)—, —SO 2 —, —SO—, —P(R a )(═O)— wherein R a is a C 1-8 alkyl or C 6-12 aryl, —C y H 2y — wherein y is an integer from 1 to 5 or a halogenated derivative thereof, or a group of the formula —O—Z—O— wherein Z is a substituted or unsubstituted aromatic C 6-24 monocyclic or polycyclic moiety optionally substituted with 1 to 6 C 1-8 alkyl groups, 1 to 8 halogen atoms, or a combination thereof, provided that the valence of Z is not exceeded. 6. The oligomer of claim 1 , being a poly(etherimide) of the formula wherein each Z is independently a substituted or unsubstituted aromatic C 6-24 monocyclic or polycyclic moiety optionally substituted with 1 to 6 C 1-8 alkyl groups, 1 to 8 halogen atoms, or a combination thereof, provided that the valence of Z is not exceeded. 7. The oligomer of claim 6 , wherein Z is a divalent group of the formula wherein each R a and R b is independently the same or different, and is a halogen atom or a monovalent C 1-6 alkyl group, p and q are each 0 to 4; c is 0 to 4; and each X a is independently the same or different, and is a single bond, —O—, —S—, —S(O)—, —S(O) 2 —, —C(O)—, or a C 1-18 hydrocarbon group. 8. The oligomer of claim 7 , wherein Z is a divalent group of the formula wherein Q is —O—, —S—, —C(O)—, —SO 2 —, —SO—, or —C y H 2y — wherein y is an integer from 1 to 5 or a halogenated derivative thereof. 9. The oligomer of claim 1 , wherein R is a substituted or unsubstituted C 6-24 arylene group, a substituted or unsubstituted straight or branched chain C 1-20 alkylene group, or a substituted or unsubstituted C 3-8 cycloalkylene group. 10. The oligomer of claim 9 , wherein R is divalent group of the formula wherein Q 1 is —O—, —S—, —C(O)—, —SO 2 —, —SO—, —P(R a )(O)— wherein W is a C 1-8 alkyl or C 6-12 aryl, —C y H 2y — wherein y is an integer from 1 to 5 or a halogenated derivative thereof, or —(C 6 H 10 ) z — wherein z is an integer from 1 to 4. 11. The oligomer of claim 10 , wherein R is m-phenylene, p-phenylene, bis(4,4′-phenylene)sulfone, bis(3,4′-phenylene)sulfone, or bis(3,3′-phenylene)sulfone. 12. A method for producing the ureido-pyrimidinone oligomer of claim 1 , the method comprising: reacting an amino-terminated oligomer of the formula with an isocytosine of the formula in the presence of a catalyst, under conditions effective to produce the ureido-pyrimidinone oligomer. 13. The method of claim 12 , wherein the amino-terminated oligomer and the isocytosine are reacted at a mole ratio of 1:3 to 1:1.1. 14. The method of claim 12 , wherein the reacting comprises reacting the amino-terminated oligomer and the isocytosine in a solvent at a first temperature for a first period of time to form a first intermediate mixture; adding the catalyst to the first intermediate mixture to form a second intermediate mixture; and heating the second intermediate mixture at a second temperature to provide the ureido-pyrimidinone oligomer. 15. The method of claim 12 , wherein the amino-terminated oligomer is of the formula 16. The oligomer of claim 1 , wherein the oligomer has at least one of an intrinsic glass transition temperature of greater than or equal to 180° C., a number average molecular weight of the ureido-pyrimidinone oligomer is 4,000 to 40,000 grams per mole, or a Young's modulus greater than or equal to a Young's modulus of the same polyetherimide without the ureido-pyrimidinone groups, and having a molar mass of greater than 16,000 grams per mole. 17. An article comprising the oligomer of claim 1 . 18. The article of claim 17 , wherein the article is a film, a fiber, a foam, or a molded part. 19. The article of claim 17 , wherein the article is a film prepared by solution-casting the oligomer. 20. The article of claim 18 , wherein the article is a film prepared by melt processing the oligomer.

Assignees

Inventors

Classifications

  • to carbodiimide or uretone-imine groups · CPC title

  • One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine · CPC title

  • with oxygen only in the tetracarboxylic moiety · CPC title

  • Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors · CPC title

  • used for fibers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10696792B2 cover?
A ureido-pyrimidinone oligomer having the formula (I) wherein each Z′ is independently the same or different, and is a substituted or unsubstituted straight or branched chain C 1-10 alkyl, each R 1 is independently the same or different, and is a substituted or unsubstituted straight or branched chain C 1-20 alkylene, substituted or unsubstituted C 2-20 alkenylene, substituted or unsubstitu…
Who is the assignee on this patent?
Sabic Global Technologies Bv
What technology area does this patent fall under?
Primary CPC classification C08G73/1053. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).